Marty and Claudia Collins
Have you ever heard of a Nrf2 activator?
Most doctors and health practitioners are not yet familiar with Nrf2 activation because the science is so new. Nothing has been available to target this metabolic pathway for therapeutic intervention until Protandim. Early studies on Nrf2 activators began coming out in 1998. By this time (June 2011) over 2000 published studies have been completed. This area of bio-medical research has accelerated quickly in the last decade, so word is just beginning to spread in the medical community. There are pharmaceutical companies racing to develop drugs for various diseases that target this genetic pathway. But Protandim is already available, proven to work, affordable, well tolerated and has none of the side effects that come along with synthetic drugs. Not only that, it is available without prescription at a very affordable price.
Sunday, February 26, 2012
0 comments:
Post a Comment